About GALLIPRO® MS
GALLIPRO® MS contains a combination of highly-selected strains of Bacillus subtilis DSM5750 and Bacillus licheniformis DSM5749, that were specifically chosen for their ability to control Clostridium perfringens proliferation and the availability of nutrients from feed. Numerous trials showed that GALLIPRO® MS improves flock performance with demonstrable economic benefits.
GALLIPRO® MS reduces the risk of Necrotic Enteritis
In a broiler study, daily feeding of GALLIPRO® MS resulted in improved performance, with significantly reduced Necrotic Enteritis lesion scores at 42 days of age. The combination of highly-selected strains of B. subtilis and B. licheniformis competitively inhibits the proliferation of C. perfringens and improves the stability and function of the GI tract. (Virginia Diversified Research Corporation, USA, 2016).
Daily feeding of Bacillus subtilis from GALLIPRO® MS improves the availability and absorption of nutrients and enables the use of our Flexible Feed Formulation concept
In a broiler trial, daily feeding of our highly-selected strain of Bacillus subtilis in a reduced energy diet (up to 4%) resulted in overall performance that was similar to the control groups at 42 days of age. (D. Harrington, M. Sims, et al, 2015, J. Appl. Poult. Res. 0: 1-11).
GALLIPRO® MS improves immune responsiveness
Daily feeding of GALLIPRO® MS was shown to significantly improve the efficacy of vaccines, such as those for Newcastle or Gumboro. Under stress from pathogenic Salmonella, the highly-selected strain of Bacillus subtilis found in GALLIPRO® MS increased antibody titers of the aforementioned vaccines (A.A. Sadeghi, et al., 2014, Probiotic & antimicro. Prot. DOI 10.1007) in broilers.